Skip to Content
Merck
CN
  • Synthesis and biological investigation of new 4''-malonyl tethered derivatives of erythromycin and clarithromycin.

Synthesis and biological investigation of new 4''-malonyl tethered derivatives of erythromycin and clarithromycin.

Bioorganic & medicinal chemistry letters (2006-01-03)
Daniel Sherman, Liqun Xiong, Alexander S Mankin, Artem Melman
ABSTRACT

A new approach to 4''-substituted derivatives of erythromycin and clarithromycin was developed by converting them into corresponding 4''-malonic monoesters. Subsequent carbodiimide coupling with alcohols and amines provided new macrolide derivatives that are capable of binding to 50S ribosomal subunits and inhibiting protein synthesis in cell-free system.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Erythromycin, potency: ≥850 μg per mg
Sigma-Aldrich
Erythromycin, BioReagent, suitable for cell culture
Sigma-Aldrich
Erythromycin, meets USP testing specifications